New York Life Insurance is reportedly engaged in discussions to buy non-health benefits division from health insurer Cigna.

The deal could be valued as much as $6bn, The Wall Street Journal reported.

Cigna non-health benefits unit offers insurance plans including accident and disability-income as well as life insurance policies.

Part of disability and other operations division, Cigna’s group benefits business reported $1.31bn of adjusted revenue in the three months to 30 June. It serves 15.4 million customers.

Reuters first reported in August that the business has been put on sale.

If the proposed deal materialises, it will strengthen New York Life business outside the core business of life insurance and annuities.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Sources familiar with the development told the publication that New York Life and Cigna are expected to announce the deal as early as this month.

However, they cautioned that there is no certainty about the deal, as other potential suitors such as Sun Life Financial and MetLife are also vying for  the business.

Cigna has been looking to cut down its debt obligations after it purchased pharmacy-benefits manager Express Scripts for a $54bn last year.

Following the completion of the transactions, Cigna debt pile rose to over $40bn.